問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2025-10-18

 莊博雅
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2022-01-05 - 2026-01-06

Phase I/II

Completed
A Phase 1/2 Dose Escalation/Expansion Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
  • Condition/Disease

    Mesothelioma

  • Test Drug

    靜脈輸注液

Participate Sites
4Sites

Recruiting4Sites